NCT01103622View on ClinicalTrials.gov

Investigate the Effect of AZD1656 on the Pharmacokinetics of Digoxin in Type 2 Diabetes Mellitus Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

AZD1656

Oral tablet bd, step-wise increased dosage

DRUG

Digoxin

Oral tablet od on Day 4

DRUG

Placebo

Oral tablet bd, step-wise increased dosage

Trial Locations (1)

Unknown

Research Site, Chula Vista

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY

NCT01103622 - Investigate the Effect of AZD1656 on the Pharmacokinetics of Digoxin in Type 2 Diabetes Mellitus Patients | Biotech Hunter | Biotech Hunter